<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Rea Press</journal-id>
      <journal-id journal-id-type="publisher-id">null</journal-id>
      <journal-title>Rea Press</journal-title><issn pub-type="ppub">3042-1322</issn><issn pub-type="epub">3042-1322</issn><publisher>
      	<publisher-name>Rea Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">https://doi.org/10.48314/ramd.vi.71</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group><subject>Temperature indices, Fuzzy graph, Autism drugs, QSPR analysis</subject></subj-group>
      </article-categories>
      <title-group>
        <article-title>On the Temperature Indices of Fuzzy Graphs and its Application forQSPR analysis on Autism drugs</article-title><subtitle>On the Temperature Indices of Fuzzy Graphs and its Application forQSPR analysis on Autism drugs</subtitle></title-group>
      <contrib-group><contrib contrib-type="author">
	<name name-style="western">
	<surname>Sadeghi </surname>
		<given-names>Mahsa </given-names>
	</name>
	<aff>Department of Mathematics, University of Mazandaran, Babolsar, Iran.</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname> Talebi</surname>
		<given-names>Ali Asghar</given-names>
	</name>
	<aff>Department of Mathematics, University of Mazandaran, Babolsar, Iran.</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Ramezani</surname>
		<given-names>Jaber </given-names>
	</name>
	<aff>Department of Mathematics, University of Mazandaran, Babolsar, Iran.</aff>
	</contrib></contrib-group>		
      <pub-date pub-type="ppub">
        <month>09</month>
        <year>2025</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>09</month>
        <year>2025</year>
      </pub-date>
      <volume>2</volume>
      <issue>3</issue>
      <permissions>
        <copyright-statement>© 2025 Rea Press</copyright-statement>
        <copyright-year>2025</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license>
      </permissions>
      <related-article related-article-type="companion" vol="2" page="e235" id="RA1" ext-link-type="pmc">
			<article-title>On the Temperature Indices of Fuzzy Graphs and its Application forQSPR analysis on Autism drugs</article-title>
      </related-article>
	  <abstract abstract-type="toc">
		<p>
			In this work, we introduce the concept of fuzzy temperature indices and rigorously compute them for fundamental fuzzy graph structures as well as their standard operators, including Cartesian products and compositions. Utilizing a graph-theoretical modeling approach, fuzzy graphs are constructed for a selection of pharmaceutical compounds commonly prescribed for Autism Spectrum Disorders (ASD), specifically Aripiprazole, Haloperidol, Risperidone, Sertraline, Venlafaxine, and Ziprasidone. The fuzzy temperature indices are then derived based on the underlying physicochemical descriptors of these compounds. Linear regression analyses are performed to explore the predictive capacity of the fuzzy topological indices in relation to drug properties. The findings highlight the significance of fuzzy temperature indices as robust mathematical invariants, providing valuable insights into the structural and functional profiling of ASD medications, and opening new avenues for the application of fuzzy graph theory in pharmaceutical sciences and computational drug design.
		</p>
		</abstract>
    </article-meta>
  </front>
  <body></body>
  <back>
    <ack>
      <p>null</p>
    </ack>
  </back>
</article>